Page last updated: 2024-10-25

cilostazol and Angor Pectoris

cilostazol has been researched along with Angor Pectoris in 3 studies

Research Excerpts

ExcerptRelevanceReference
"Cilostazol is an effective therapy for patients with VSA uncontrolled by conventional amlodipine therapy, and has no serious side effects."2.79A randomised, multicentre, double blind, placebo controlled trial to evaluate the efficacy and safety of cilostazol in patients with vasospastic angina. ( Hong, YJ; Jeong, YH; Kim, JH; Kim, JS; Kim, MH; Lee, CW; Lee, JH; Lee, JY; Nam, CW; Park, Y; Shin, ES; Shin, HK; Tahk, SJ; Yoo, SY, 2014)
"Cilostazol is a selective inhibitor of phosphodiesterase 3 that increases intracellular cyclic adenosine monophosphate (cAMP) contents."1.39Efficacy of cilostazol on uncontrolled coronary vasospastic angina: a pilot study. ( Chun, KJ; Kim, J; Kim, JH; Kim, JS; Lee, JH; Park, YH; Shin, ES; Song, SG; Yoo, SY, 2013)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shin, ES2
Lee, JH2
Yoo, SY2
Park, Y1
Hong, YJ1
Kim, MH1
Lee, JY1
Nam, CW1
Tahk, SJ1
Kim, JS2
Jeong, YH1
Lee, CW1
Shin, HK1
Kim, JH2
Song, SG1
Park, YH1
Kim, J1
Chun, KJ1
Watanabe, K1
Ikeda, S1
Komatsu, J1
Inaba, S1
Suzuki, J1
Sueda, S1
Funada, J1
Kitakaze, M1
Sekiya, M1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Therapeutic Exploratory Study to Evaluate the Efficacy and Safety of PletaalĂ’(Cilostazol) in Subjects With Vasospastic Angina (STELLA)[NCT01444885]Phase 250 participants (Actual)Interventional2011-10-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for cilostazol and Angor Pectoris

ArticleYear
A randomised, multicentre, double blind, placebo controlled trial to evaluate the efficacy and safety of cilostazol in patients with vasospastic angina.
    Heart (British Cardiac Society), 2014, Volume: 100, Issue:19

    Topics: Adult; Angina Pectoris; Chest Pain; Cilostazol; Coronary Vasospasm; Dose-Response Relationship, Drug

2014
Effect of cilostazol on vasomotor reactivity in patients with vasospastic angina pectoris.
    The American journal of cardiology, 2003, Jul-01, Volume: 92, Issue:1

    Topics: Angina Pectoris; Cilostazol; Coronary Circulation; Endothelium, Vascular; Female; Hemodynamics; Huma

2003

Other Studies

1 other study available for cilostazol and Angor Pectoris

ArticleYear
Efficacy of cilostazol on uncontrolled coronary vasospastic angina: a pilot study.
    Cardiovascular therapeutics, 2013, Volume: 31, Issue:3

    Topics: Adult; Aged; Angina Pectoris; Cilostazol; Coronary Vasospasm; Female; Humans; Male; Middle Aged; Pho

2013